PHIO - Phio Pharmaceuticals regains compliance with Nasdaq listing rules
- Phio Pharmaceuticals ( NASDAQ: PHIO ) has received a letter from The Nasdaq advising the Company that it has regained complianc e with Nasdaq's minimum bid price listing requirement.
- Phio has satisfied the terms by complying with the minimum bid price requirement of $1/share under Nasdaq Listing Rule.
For further details see:
Phio Pharmaceuticals regains compliance with Nasdaq listing rules